Wellington Shields & Co., LLC Royalty Pharma PLC Transaction History

Wellington Shields & Co., LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$39.17 - $44.04 $2.1 Million - $2.36 Million	-53,559 Reduced 60.95%	34,318 $1.36 Million
Q4 2021 Feb 15, 2022	SELL	$35.17 - $42.48 $115,814 - $139,886	-3,293 Reduced 3.61%	87,877 $3.5 Million
Q2 2021 Aug 12, 2021	SELL	$39.85 - $46.63 $99,625 - $116,575	-2,500 Reduced 2.67%	91,170 $3.74 Million
Q1 2021 May 12, 2021	SELL	$42.34 - $52.82 $42,340 - $52,820	-1,000 Reduced 1.06%	93,670 $4.09 Million
Q4 2020 Feb 09, 2021	BUY	$36.12 - $50.05 $3.42 Million - $4.74 Million	94,670 New	94,670 $4.74 Million

412

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Wellington Shields & Co., LLC, based on Form 13F filings with the SEC.

Stay updated on Wellington Shields & Co., LLC with notifications on news.